<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>MS 2016 num. 11</title>
<link href="http://hdl.handle.net/10608/8788" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/10608/8788</id>
<updated>2026-04-05T15:14:55Z</updated>
<dc:date>2026-04-05T15:14:55Z</dc:date>
<entry>
<title>Chroniques génomiques - Les débuts de CRISPR en thérapie génique</title>
<link href="http://hdl.handle.net/10608/9006" rel="alternate"/>
<author>
<name>Jordan, Bertrand</name>
</author>
<id>http://hdl.handle.net/10608/9006</id>
<updated>2021-05-26T06:45:00Z</updated>
<published>2016-01-01T00:00:00Z</published>
<summary type="text">Chroniques génomiques - Les débuts de CRISPR en thérapie génique
Jordan, Bertrand
Two clinical trials using CRISPR technology to engineer the T cells of cancer patients by inactivating the gene for immune checkpoint molecule PD-1 are (almost) underway, one in the USA and the other in China. The less sophisticated Chinese trial seems slated to begin first, in part because of very speedy approval ; it may however trigger autoimmune reactions that could be very serious.
</summary>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Le cortex visuel : entre changement et équilibre</title>
<link href="http://hdl.handle.net/10608/9004" rel="alternate"/>
<author>
<name>Bachatene, Lyes</name>
</author>
<author>
<name>Bharmauria, Vishal</name>
</author>
<author>
<name>Cattan, Sarah</name>
</author>
<author>
<name>Chanauria, Nayan</name>
</author>
<author>
<name>Etindele Sosso, Faustin Armel</name>
</author>
<author>
<name>Molotchnikoff, Stéphane</name>
</author>
<id>http://hdl.handle.net/10608/9004</id>
<updated>2021-05-26T06:45:02Z</updated>
<published>2016-01-01T00:00:00Z</published>
<summary type="text">Le cortex visuel : entre changement et équilibre
Bachatene, Lyes; Bharmauria, Vishal; Cattan, Sarah; Chanauria, Nayan; Etindele Sosso, Faustin Armel; Molotchnikoff, Stéphane
</summary>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>L’élimination des cellules sénescentes : vers un avenir meilleur ?</title>
<link href="http://hdl.handle.net/10608/9005" rel="alternate"/>
<author>
<name>Chauvet, Véronique</name>
</author>
<author>
<name>Jouaville, Soukie</name>
</author>
<author>
<name>Garbez, Nicolas</name>
</author>
<author>
<name>Martins, Isabelle</name>
</author>
<id>http://hdl.handle.net/10608/9005</id>
<updated>2021-05-26T06:45:01Z</updated>
<published>2016-01-01T00:00:00Z</published>
<summary type="text">L’élimination des cellules sénescentes : vers un avenir meilleur ?
Chauvet, Véronique; Jouaville, Soukie; Garbez, Nicolas; Martins, Isabelle
</summary>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Hépatopathies stéatosiques non alcooliques : Perte sélective des lymphocytes T CD4+ et développement d’un cancer du foie</title>
<link href="http://hdl.handle.net/10608/9003" rel="alternate"/>
<author>
<name>L’Hermitte, Antoine</name>
</author>
<author>
<name>Pham, Sandrine</name>
</author>
<author>
<name>Cadoux, Mathilde</name>
</author>
<author>
<name>Couty, Jean-Pierre</name>
</author>
<id>http://hdl.handle.net/10608/9003</id>
<updated>2021-05-26T06:44:56Z</updated>
<published>2016-01-01T00:00:00Z</published>
<summary type="text">Hépatopathies stéatosiques non alcooliques : Perte sélective des lymphocytes T CD4+ et développement d’un cancer du foie
L’Hermitte, Antoine; Pham, Sandrine; Cadoux, Mathilde; Couty, Jean-Pierre
</summary>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</entry>
</feed>
